Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 10:5:13931.
doi: 10.1038/srep13931.

Action mechanism of corticosteroids to aggravate Guillain-Barré syndrome

Affiliations

Action mechanism of corticosteroids to aggravate Guillain-Barré syndrome

Yu-Zhong Wang et al. Sci Rep. .

Abstract

Corticosteroids have been proved to be ineffective for Guillain-Barré syndrome, but the mechanism remains unknown. In a rabbit model of axonal Guillain-Barré syndrome, treatment with corticosteroids significantly reduced macrophage infiltration in the spinal ventral roots and the survival rate as well as clinical improvement. On 30(th) day after onset, there was significantly higher frequency of axonal degeneration in the corticosteroids-treated rabbits than saline-treated rabbits. Corticosteroids may reduce the scavengers that play a crucial role for nerve regeneration, thus delay the recovery of this disease.

PubMed Disclaimer

Conflict of interest statement

Prof. Yuki receives grant support from the Singapore National Medical Research Council (IRG 10nov086 and CSA/047/2012 to N.Y.) and serves as an editorial board member of Expert Review of Neurotherapeutics, The Journal of the Neurological Sciences, The Journal of Peripheral Nervous System, Journal of Neurology, Neurosurgery & Psychiatry and Journal of Alzheimer’s disease. The other authors have no financial disclosure.

Figures

Figure 1
Figure 1
(A) Staining of macrophage infiltration in the spinal ventral roots of acute motor axonal neuropathy (AMAN) rabbits one week after disease onset in methylprednisolone and saline groups. Scale bars indicate 200  μm. There was significant reduction of macrophage infiltration in methylprednisolone group than saline group. The numbers 1–6 represent the serial number of AMAN rabbits in different groups. The results were shown as mean ± standard error. (B) Voltage-gated sodium (Nav) channels cluster disruption and C3 deposition at the nodes of Ranvier in spinal ventral roots of AMAN rabbits. Representative immunofluorescence images of longitudinal sections of spinal ventral roots from the rabbits (50  μm). The activated C3 fragments were stained in green, Nav channels in red. As shown, the nodal Nav channel cluster is markedly disrupted together with the activated C3 fragment deposition in both methylprednisolone group and saline group. There was no difference in frequency of both Nav channel cluster disruption and activated C3 fragment deposition between methylprednisolone and saline groups. The numbers 1–6 represent the serial number of AMAN rabbits in different groups. The results were shown as mean ± standard error.
Figure 2
Figure 2
(A) Survival curves of rabbits up till 30 days after disease onset were shown. Five out of twelve rabbits died by day 30 after disease onset in methylprednisolone group. There was significant difference between the survival curves of methylprednisolone and saline groups (p = 0.04). (B) Changes in the clinical score (mean ± standard error) during the 30 days after disease onset. *p = 0.01.
Figure 3
Figure 3. Histological changes in the ventral roots of AMAN rabbits and the normal control were shown.
Scale bars indicate 50 μm. The frequency of axonal degeneration was significantly higher in methylprednisolone group (n = 7) than the saline group (n = 9) on the 30th day after the initiation of treatment (p < 0.001). The results were shown as mean ± standard error.

References

    1. Hughes R. A. C., Newsom-Davis J. M., Perkin G. D. & Pierce J. M. Controlled trial prednisolone in acute polyneuropathy. Lancet 2, 750–753, (1978). - PubMed
    1. Guillain-Barré Syndrome Steroid Trial Group. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet 341, 586–590 (1993). - PubMed
    1. Hafer-Macko C. E. et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39, 625–635, (1996). - PubMed
    1. Hafer-Macko C. et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40, 635–644, 10.1002/ana.410400414 (1996). - DOI - PubMed
    1. Susuki K. et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27, 3956–3967, 10.1523/JNEUROSCI.4401-06.2007 (2007). - DOI - PMC - PubMed

Publication types

MeSH terms

Substances